Catalyst Wire Dossier Catalyst Wire Dossier

bendammustine

bendamustine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bendammustine, covering 2020-06-11 to 2020-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO) [Phase 2]

See pricing